Reid Waldman, MD

Reid Waldman, MD, is a dermatologist and chief executive officer of Veradermics.

Articles by Reid Waldman, MD

Executive Insights: Extended-Release Oral Minoxidil Shows Optimized Pharmacokinetics and Potential to Enhance Hair Growth

ByChristopher G. Bunick, MD, PhD,Reid Waldman, MD,Kaitlyn Bader, Assistant Managing Editor

March 29th 2026

At AAD 2026, Christopher Bunick, MD, PhD, and Reid Waldman, MD, discuss investigational VDPHL01, extended-release oral minoxidil, for the treatment of women and men with pattern hair loss.

Latest Updated Articles

Executive Insights: Extended-Release Oral Minoxidil Shows Optimized Pharmacokinetics and Potential to Enhance Hair Growth
March 29th 2026

Reid Waldman, MD

Articles by Reid Waldman, MD

Executive Insights: Extended-Release Oral Minoxidil Shows Optimized Pharmacokinetics and Potential to Enhance Hair Growth

Latest Updated Articles

Trending on Dermatology Times

Social Media Mythbusters: The Summer Skin Care "Shutdown"

Zasocitinib Shows High Skin Clearance at Hard-to-Treat Psoriasis Sites

Breakout Bulletin: July 13-July 17

ED Treatment Gaps Persist for Pediatric Atopic Dermatitis

New York Extends Nurse Practitioner Independent Practice Authority Through 2030